Clinical Trials · NCT02243098
Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 31
- Start date
- Sep 2014
- Locations
- 1 site, Germany
- Primary endpoint
- Area under the atorvastatin plasma concentration-time curve